Thymosin alpha-1 as an immune booster: what TikTok gets wrong

What did @the_designgirl actually say?

The creator introduced thymosin alpha-1 as a new addition to her peptide stack, which already includes tirzepatide ("15 mg's of tris") and glutathione injections. She described it as something "supposed to help with immunity" and make you "feel good," and noted she started at a quarter of her intended dose to screen for side effects. That cautious dosing approach is worth flagging separately, because the rest of the framing, specifically the TikTok caption promising "immune-boosting" effects and "calming inflammation," runs ahead of what her actual transcript supports. She did not claim it cures anything. She was measured. The caption, though, is doing a lot of heavy lifting the science can only partially carry.

She also described an injection site reaction from glutathione, redness and swelling about the size of a quarter, managed with cortisone cream. That detail is clinically relevant and she was right to mention it.

Does the science back this up?

Partially, yes, but with real caveats about context and population. Thymosin alpha-1 (TA1) is a naturally occurring peptide derived from the thymus gland, and it does have documented immunomodulatory effects. The strongest human evidence comes from specific disease contexts, not general wellness.

A 2020 randomized controlled trial by Liu et al. published in Clinical Infectious Diseases found TA1 reduced 28-day mortality in severe COVID-19 patients with lymphopenia. A 2018 meta-analysis by Shrivastava et al. in Expert Opinion on Biological Therapy found benefits in hepatitis B and certain cancers when used alongside standard treatment. Thymalfasin (the pharmaceutical-grade TA1, sold as Zadaxin) is approved in several countries for hepatitis B and as an adjunct in some cancers. None of these trials were conducted in healthy adults seeking general immune optimization. The jump from "works in critically ill patients" to "biohack queen energy" is not supported.

What did they get wrong (or right)?

She got the cautious approach right. Starting at a fraction of the intended dose to monitor for adverse reactions is genuinely sensible, and more responsible than most peptide content on TikTok. Credit where it is due.

What she got wrong, or at least what the caption got wrong on her behalf, is the framing. Describing TA1 as "the immune-boosting peptide your body actually makes on its own" implies a straightforward supplementation logic, like taking magnesium because you are deficient. That is not how TA1 works clinically. Its effects are context-dependent and most studied in immune-compromised states. There is no reliable human evidence that exogenous TA1 improves immune function in healthy, immunocompetent adults. A 2021 review by Tuthill et al. in International Immunopharmacology noted that most TA1 trials have methodological limitations and that effects in healthy populations remain largely uncharacterized.

The glutathione injection site reaction she described, redness and localized swelling, is a known adverse effect of subcutaneous glutathione and is worth monitoring beyond cortisone cream alone if it recurs.

What should you actually know?

Thymosin alpha-1 is a real peptide with real pharmacological activity. It is not a wellness supplement with proven benefits in healthy people. The gap between its clinical evidence base and how it is marketed in biohacking circles is significant.

Compounded TA1 is not equivalent to pharmaceutical-grade thymalfasin. Compounded peptides are not FDA-approved, and their purity, potency, and sterility are not independently verified in the same way. That distinction matters, especially when injecting something subcutaneously.

Running multiple injectable peptides simultaneously, TA1, glutathione, and tirzepatide, without physician oversight is not a "stack" in any clinically validated sense. Interaction data for these combinations in humans essentially does not exist. If you are curious about TA1, that conversation starts with a licensed provider who has reviewed your immune panel, not a TikTok caption.

• TA1 is only approved (as Zadaxin) in select countries for hepatitis B and cancer adjunct therapy, not for general immune support.
• Injection site reactions from glutathione, like the one described, can indicate local irritation or an immune response and should be tracked, not just managed with cortisone.
• Compounded peptides are not FDA-regulated for safety or efficacy.